HOOKIPA Pharma Inc (HOOK)
0.811
-0.05
(-5.59%)
USD |
NASDAQ |
May 16, 16:00
0.82
+0.01
(+1.11%)
After-Hours: 07:28
HOOKIPA Pharma Cash from Financing (Quarterly): -0.135M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -0.135M |
December 31, 2023 | 21.25M |
September 30, 2023 | -0.659M |
June 30, 2023 | 45.82M |
March 31, 2023 | -0.735M |
December 31, 2022 | -0.196M |
September 30, 2022 | 0.127M |
June 30, 2022 | -2.953M |
March 31, 2022 | 75.29M |
December 31, 2021 | -0.41M |
September 30, 2021 | -0.011M |
June 30, 2021 | 0.085M |
March 31, 2021 | 0.101M |
Date | Value |
---|---|
December 31, 2020 | 75.08M |
September 30, 2020 | -0.222M |
June 30, 2020 | -0.15M |
March 31, 2020 | -1.284M |
December 31, 2019 | -0.883M |
September 30, 2019 | -0.532M |
June 30, 2019 | 76.01M |
March 31, 2019 | 35.16M |
December 31, 2018 | 0.006M |
September 30, 2018 | -0.005M |
June 30, 2018 | -0.007M |
March 31, 2018 | 6.879M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-2.953M
Minimum
Jun 2022
76.01M
Maximum
Jun 2019
14.28M
Average
-0.1425M
Median
Cash from Financing (Quarterly) Benchmarks
Absci Corp | 81.18M |
NovaBay Pharmaceuticals Inc | -0.597M |
Palatin Technologies Inc | 4.974M |
iBio Inc | 4.005M |
Theriva Biologics Inc | 0.00 |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -24.16M |
Cash from Investing (Quarterly) | -0.116M |
Free Cash Flow | -82.83M |
Free Cash Flow Per Share (Quarterly) | -0.1927 |
Free Cash Flow to Equity (Quarterly) | -24.30M |
Free Cash Flow to Firm (Quarterly) | -24.27M |
Free Cash Flow Yield | -94.69% |